Concepedia

David Hermanson

DH

Statistics

Publications

19

Citations

2.2K

H-Index

15

Active since

2007

Affiliations

University of Minnesota(Current)

Twin Cities Orthopedics

Ollscoil na Gaillimhe – University of Galway

Tufts University

Orbsen Therapeutics (Ireland)

David Hermanson is an author at University of Minnesota specializing in oncology, immunology, and medicine.

Publications per year

2007–2022

19

Publications

19

Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity

Ye Li, David Hermanson, Branden S. Moriarity et al. · Cell stem cell · 2018 · 988 citations · Full text

, , +10

Clinical-Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer Therapy

David A. Knorr, Zhenya Ni, David Hermanson et al. · Stem Cells Translational Medicine · 2013 · 415 citations · Full text

, , +17

Induced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian Cancer

David Hermanson, Laura E. Bendzick, Lee J. Pribyl et al. · Stem Cells · 2015 · 243 citations · Full text

, , +15

Structure−Activity Relationship and Molecular Mechanisms of Ethyl 2-Amino-4-(2-ethoxy-2-oxoethyl)-6-phenyl-4<i>H</i>-chromene-3-carboxylate (sHA 14-1) and Its Analogues

Sonia G. Das, Jignesh Doshi, Defeng Tian et al. · Journal of Medicinal Chemistry · 2009 · 75 citations · Full text

, , +16

Structure–Activity Relationship and Molecular Mechanisms of Ethyl 2-Amino-6-(3,5-dimethoxyphenyl)-4-(2-ethoxy-2-oxoethyl)-4<i>H</i>-chromene-3-carboxylate (CXL017) and Its Analogues

Sonia G. Das, Balasubramanian Srinivasan, David Hermanson et al. · Journal of Medicinal Chemistry · 2011 · 59 citations

, , +12

1–5 of 19